JAC Advance Access published online on September 3, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh414
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Instituto Nacional de Perinatología, Mexico City, Mexico
* To whom correspondence should be addressed. E-mail: carlos.amabile{at}lusara.org.
Objective: To compare the bacteriological and clinical efficacy of three treatments for uncomplicated cystitis in ambulatory pre-menopausal women: ciprofloxacin 250 mg orally twice daily for 3 days, trimethoprim/sulfamethoxazole 160/800 mg orally twice daily for 7 days, and norfloxacin 400 mg orally twice daily for 7 days. Materials and methods: A total of 455 women were randomly assigned to three treatment groups: 151 received ciprofloxacin, 150 received trimethoprim/sulfamethoxazole, and 154 received norfloxacin. Bacteriological cure and clinical resolution were evaluated 5-9 days and 4-6 weeks after completion of treatment. Results: There was no significant difference among the three treatment groups: overall efficacy ranged from 78.5% for the trimethoprim/sulfamethoxazole group, to 84.5% for the ciprofloxacin group. The highest overall incidence of drug-related adverse effects occurred in the trimethoprim/sulfamethoxazole patients. Conclusions: These data indicate that a 3 day treatment with ciprofloxacin is at least as clinically and bacteriologically effective as 7 day treatments with trimethoprim/sulfamethoxazole and norfloxacin for uncomplicated lower urinary tract infections.
Accepted July 24, 2004
Brief report
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study
,
,
2 Hospital General de México, Mexico City, Mexico
3 Hospital Clínica del Parque, Chihuahua, Mexico
4 Hospital Eugenio Espejo, Quito, Ecuador
5 Hospital del Sur, Quito, Ecuador
6 Hospital de Maternidad, San Salvador, El Salvador
7 Hospital Vargas de Caracas, Caracas, Venezuela
8 Fundación Lusara, Apartado Postal 102-006, 08930, Mexico City, Mexico
9 Bayer de México, Dirección Médica, Mexico City, Mexico
10 Química Farmacéutica Bayer, Barcelona, Spain
![]()
Abstract
Present address. Unidad de Apoyo a la Investigación Clínica, Instituto Nacional de Pediatría, Mexico City, Mexico.
Present address. Hospital CIMA, Chihuahua, Mexico.
Members of the uUTI Latin American Study Group are listed in the Acknowledgements.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Nys, T. van Merode, A. I. M. Bartelds, and E. E. Stobberingh Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture J. Antimicrob. Chemother., May 1, 2006; 57(5): 955 - 958. [Abstract] [Full Text] [PDF] |
||||
